Literature DB >> 26781757

Multimodality imaging of osseous involvement In haematological malignancies.

Abhishek R Keraliya1,2, Katherine M Krajewski1,2, Jyothi P Jagannathan1,2, Atul B Shinagare1,2, Marta Braschi-Amirfarzan1,2, Sree H Tirumani1,2, Nikhil H Ramaiya1,2.   

Abstract

The purpose of this article is to provide a comprehensive review of the imaging features of osseous involvement in haematological malignancies. Osseous involvement can be seen in various haematological malignancies including lymphomas, plasma cell neoplasms, leukaemias and myeloproliferative neoplasms. Imaging plays a crucial role in initial diagnosis, staging and in the assessment of treatment response in these patients.

Entities:  

Mesh:

Year:  2016        PMID: 26781757      PMCID: PMC4986506          DOI: 10.1259/bjr.20150980

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  63 in total

Review 1.  Bone marrow imaging.

Authors:  J B Vogler; W A Murphy
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

2.  The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.

Authors:  B Zhang; S M Lewis
Journal:  Eur J Haematol       Date:  1989-07       Impact factor: 2.997

3.  Radiographic manifestations of multiple myeloma in the mandible: a retrospective study of 77 patients.

Authors:  C Witt; A C Borges; K Klein; H J Neumann
Journal:  J Oral Maxillofac Surg       Date:  1997-05       Impact factor: 1.895

4.  Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

Authors:  M G Conlan; M Bast; J O Armitage; D D Weisenburger
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

Review 5.  Imaging findings in patients with myelofibrosis.

Authors:  A Guermazi; E de Kerviler; D Cazals-Hatem; A M Zagdanski; J Frija
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

6.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Authors:  Twyla B Bartel; Jeff Haessler; Tracy L Y Brown; John D Shaughnessy; Frits van Rhee; Elias Anaissie; Terri Alpe; Edgardo Angtuaco; Ronald Walker; Joshua Epstein; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

7.  Musculoskeletal manifestations in pediatric acute leukemia.

Authors:  Riccardo Sinigaglia; Cosimo Gigante; Gianluca Bisinella; Stefania Varotto; Luigi Zanesco; Sisto Turra
Journal:  J Pediatr Orthop       Date:  2008 Jan-Feb       Impact factor: 2.324

8.  Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.

Authors:  Colleen M Costelloe; Hubert H Chuang; John E Madewell; Naoto T Ueno
Journal:  J Cancer       Date:  2010-06-28       Impact factor: 4.207

9.  Musculoskeletal problems in pediatric acute leukemia.

Authors:  Ilaria Riccio; Marco Marcarelli; Nicola Del Regno; Claudia Fusco; Martina Di Martino; Raffaele Savarese; Giovanna Gualdiero; Matilde Oreste; Cristiana Indolfi; Giovanni Porpora; Marco Esposito; Fiorina Casale; Giovanni Riccardi
Journal:  J Pediatr Orthop B       Date:  2013-05       Impact factor: 1.041

10.  Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment.

Authors:  Cody A Koch; Chin-Yang Li; Ruben A Mesa; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2003-10       Impact factor: 7.616

View more
  2 in total

Review 1.  Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment.

Authors:  António Proença Caetano; Vasco V Mascarenhas; Pedro M Machado
Journal:  Front Med (Lausanne)       Date:  2021-04-22

2.  Bone marrow abnormalities detected by magnetic resonance imaging as initial sign of hematologic malignancies.

Authors:  Ida Sofie Grønningsæter; Aymen Bushra Ahmed; Nils Vetti; Silje Johansen; Øystein Bruserud; Håkon Reikvam
Journal:  Clin Pract       Date:  2018-06-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.